Literature DB >> 23161904

Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort.

Karine Briot1, Anne Durnez, Simon Paternotte, Corinne Miceli-Richard, Maxime Dougados, Christian Roux.   

Abstract

OBJECTIVES: To assess bone mineral density (BMD) at lumbar spine and hip in a large cohort of patients with early inflammatory back pain (IBP) suggestive of axial spondyloarthritis (SpA), and to assess systemic and bone inflammation (according to MRI) as risk factors of low BMD. PATIENTS AND METHODS: 332 (52.4% male) patients with IBP suggestive of axial SpA defined by Calin or Berlin criteria were recruited; they had lumbar spine and hip BMD and body composition measurements. Low BMD was defined by Z≤-2 (at least one site). Clinical, biological (erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)) and imaging (x-rays, spine and sacroiliac joint MRI) parameters were compared in patients with and without low BMD (Z≤-2). Significant parameters in univariate analysis were tested in multivariate models.
RESULTS: Patients (mean age 33.8 years) had a short duration of axial symptoms (mean 1.6 years); 71.4% fulfilled the Assessment of Spondyloarthritis International Society criteria for axial SpA and HLA-B27 was present in 62.1%. 43 (13.0%) had low BMD (88% male). Multivariate logistic regression showed that parameters significantly associated with low BMD (any site) were the presence of bone marrow oedema (inflammatory lesions) on MRI (OR 4.63, p=0.001), either ESR or CRP (OR 2.60, p=0.037) and male gender (OR 9.60, p=0.0004).
CONCLUSIONS: This study conducted in a large cohort of young adults with early IBP suggestive of SpA shows that 13.0% of patients have a low BMD and that the main risk factor associated with low BMD was inflammation on MRI.

Entities:  

Keywords:  Bone Mineral Density; Osteoporosis; Spondyloarthritis

Mesh:

Substances:

Year:  2012        PMID: 23161904     DOI: 10.1136/annrheumdis-2012-201845

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

Review 1.  Advances and challenges in spondyloarthritis imaging for diagnosis and assessment of disease.

Authors:  Ulrich Weber; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

Review 2.  Inflammatory diseases and bone fragility.

Authors:  K Briot; P Geusens; I Em Bultink; W F Lems; C Roux
Journal:  Osteoporos Int       Date:  2017-09-15       Impact factor: 4.507

3.  Bone mineral density in patients with symptoms suggestive of spondyloarthritis.

Authors:  M Forien; A Moltó; A Etcheto; M Dougados; C Roux; K Briot
Journal:  Osteoporos Int       Date:  2015-01-28       Impact factor: 4.507

4.  Bone mass in axial spondyloarthritis: A literature review.

Authors:  Erkan Kilic; Salih Ozgocmen
Journal:  World J Orthop       Date:  2015-03-18

Review 5.  Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis.

Authors:  Rachael Stovall; Irene E van der Horst-Bruinsma; Shao-Hsien Liu; Tamara Rusman; Lianne S Gensler
Journal:  Nat Rev Rheumatol       Date:  2022-09-15       Impact factor: 32.286

6.  Vertebral Bone Mineral Density, Vertebral Strength, and Syndesmophyte Growth in Ankylosing Spondylitis: The Importance of Bridging.

Authors:  Sovira Tan; Hadi Bagheri; David Lee; Ahmad Shafiei; Tony M Keaveny; Lawrence Yao; Michael M Ward
Journal:  Arthritis Rheumatol       Date:  2022-06-27       Impact factor: 15.483

Review 7.  Bone Involvement in Patients with Spondyloarthropathies.

Authors:  Willem Lems; Corinne Miceli-Richard; Judith Haschka; Andrea Giusti; Gitte Lund Chistensen; Roland Kocijan; Nicolas Rosine; Niklas Rye Jørgensen; Gerolamo Bianchi; Christian Roux
Journal:  Calcif Tissue Int       Date:  2022-01-23       Impact factor: 4.333

8.  Trends in fractures in patients with spondyloarthritis: a nationwide population-based study (TREND-EspA study).

Authors:  Ramon Mazzucchelli; Raquel Almodovar; Elisa Dieguez-Costa; Natalia Crespi Villarias; Elia Pérez-Fernandez; Alberto García-Vadillo
Journal:  Osteoporos Int       Date:  2021-08-02       Impact factor: 4.507

Review 9.  Glucocorticoid-induced osteoporosis.

Authors:  Karine Briot; Christian Roux
Journal:  RMD Open       Date:  2015-04-08

Review 10.  Inflammation, bone loss and fracture risk in spondyloarthritis.

Authors:  Karine Briot; Christian Roux
Journal:  RMD Open       Date:  2015-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.